Generex Biotechnology Corp.   Report issue

For profit Phase 2 Phase 3
Founded: Toronto ON Canada (1983)
Status: No NME R&D (1983)

Organization Overview

First Clinical Trial
2007
NCT00524277
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Antigen Express, Inc | Antigen Express, Inc.